Clinical Trials on Schizophrenia, Paranoid

Total 3769 results

Zhu Dian

Active, not recruiting

Embedded Narrative in Interactive Game Design for Improving Medication Adherence of Schizophrenia

Medication Adherence | Schizophrenia and Related Disorders | Gamification | Mental Health Issue

China
Centre for Addiction and Mental Health
University Health Network, Toronto; Schizophrenia Society of Ontario

Withdrawn

Deep Brain Stimulation (DBS) for the Management of Treatment Refractory Negative Symptoms in Schizophrenia

Schizophrenia; Negative Type

Canada
Centre de Recherche de l'Institut Universitaire...

Unknown

Investigator Initiated Study - Asenapine Early Psychosis

Disorders | Schizophrenia and Disorders With Psychotic Features

Canada
Aalborg University Hospital

Completed

Recruitment of Patients Through Invitation Letters

Recruitment, Invitation Letters, Patients With Schizophrenia

Denmark
The Hong Kong Polytechnic University

Completed

Efficacy of Computer-assisted Cognitive Remediation in Patients With Schizophrenia

Cognitive Impairment | Executive Function | Efficacy | Schizophrenia; Psychosis | Randomized Controlled Trial

Hong Kong
Sunovion

Completed

Effect of Calories and Fat Content on the Pharmacokinetics of Lurasidone HCl

Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder

United States
Centre for Addiction and Mental Health

Recruiting

Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity (Sema)

Schizophrenia Spectrum Disorders

Canada
Shanghai Mental Health Center

Recruiting

Deep Transcranial Magnetic Stimulation for the Treatment of Treatment Resistance Schizophrenia

Deep Transcranial Magnetic Stimulation for the Treatment of Treatment Resistance Schizophrenia

China
Instituto de Investigación Hospital Universitario...
Carlos III Health Institute; European Regional Development Fund

Completed

Effectiveness of a Mindfulness-based Group Training Addressing Social Cognition in First Episode Psychosis (AGES-Mind) (AGES-Mind)

Schizophrenia and Disorders With Psychotic Features | Psychotic Episode

Spain
Haukeland University Hospital
Helse Stavanger HF; St. Olavs Hospital

Terminated

The Norwegian Prednisolone in Early Psychosis Study (NorPEPS)

Cognitive Change | Psychosis | Schizophrenia and Related Disorders | Immune Suppression

Norway
The Hong Kong Polytechnic University
University of Turku; University of Helsinki; Kowloon Hospital, Hong Kong; Pamela... and other collaborators

Completed

Video Games Among People With Schizophrenia (GAME-S)

Cognitive Function | Schizophrenia and Disorders With Psychotic Features

Hong Kong
Novartis Pharmaceuticals

Completed

Effect of AQW051 on Cognitive Function in Patients With Chronic Stable Schizophrenia

Schizophrenia Disorders

United States
University of Ottawa
The Ottawa Hospital

Unknown

Effects of CDP-Choline on Gating and Cognitive Deficits in First Episode Schizophrenia

First Episode Schizophrenia

Canada
Shanghai Jiao Tong University School of Medicine
Guangzhou Psychiatric Hospital; Suzhou Psychiatric Hospital; Tianjin Anding Hospital and other collaborators

Recruiting

Repetitive Transcranial Magnetic Stimulation in Early Psychosis and The Functional Connectivity Biotypes

Schizophrenia; Psychosis | Clinical High Risk | First Episode Psychosis

China
Centre for Addiction and Mental Health

Recruiting

"Extended" (Alternate Day) Antipsychotic Dosing

Drug Therapy | Schizophrenia and Related Disorders | Antipsychotic Agents | Drug Administration Schedule

Canada
Centre for Addiction and Mental Health
Ontario Ministry of Health and Long Term Care

Recruiting

Topiramate and Schizophrenia: Effects on Weight and Psychopathology

Schizophrenia, Schizoaffective Disorder

Canada
VA Office of Research and Development

Completed

Comparison of E-health vs. In-person Multi-Family Group (MFG)

Schizophrenia | Schizoaffective Disorder | Schizophrenia and Related Disorders

United States
Sichuan University

Unknown

Pilot Study to Evaluate the Efficacy and Safety of Quetiapine Fumarate Instant-Release (Seroquel IR) in Controlling Agitation and Aggressive Symptoms in the Acute Treatment of Patients With Schizophrenia

Acute Schizophrenia

China
Ciusss de L'Est de l'Île de Montréal
Canadian Institutes of Health Research (CIHR)

Recruiting

Comparaison of Avatar Therapy to Cognitive Behavioral Therapy in Schizophrenia With Treatment Refractory Hallucinations (Phase3)

Treatment-resistant Schizophrenia | Auditory Hallucination, Verbal

Canada
Northwell Health
National Institute of Mental Health (NIMH)

Recruiting

Targeting Processing Speed Deficits to Improve Social Functioning and Lower Psychosis Risk (SCORES)

Psychosis | Prodromal Schizophrenia | Prodromal Symptoms

United States
University of California, Los Angeles

Completed

Treatment of Cognitive and Negative Symptoms in Schizophrenia With N-acetylcysteine (NAC2)

Schizophrenia | Cognitive Deficits | Schizophrenia; Negative Type

United States
Psychiatric Hospital of the University of Basel

Active, not recruiting

CBD Cigarettes Instead of Normal Cigarettes as Innovative Treatment for Schizophrenia

Harm Reduction | Schizophrenia and Other Psychotic Disorders

Switzerland
Centre for Addiction and Mental Health
Janssen Inc.

Recruiting

Risk of Breakthrough Symptoms With Long-Acting Injectable Medications

Schizophrenia | Schizophrenia Relapse

Canada
Tri-Service General Hospital

Recruiting

Online HD-tDCS Over the Left DLPFC During a Working Memory Task for Treating Negative Symptoms of Schizophrenia

Schizophrenia | Negative Symptoms in Schizophrenia | Schizoaffective Disorder, Mixed Type

Taiwan
Assistance Publique - Hôpitaux de Paris

Recruiting

COG-PSYCHO : Social Cognition and Psychotic Characteristics: Genetic and Phenomic Approach (COG-PSYCHO)

Social Cognition of Schizophrenia, Bipolas or Depressed Patients

France
Christina Andreou

Recruiting

Metacognitive Training as a Serious Game (Macu'ta)

Psychotic Disorders | Schizophrenia and Related Disorders | Delusions

Germany, Switzerland
Xiaoduo Fan

Terminated

Telmisartan Pilot Study on Treatment Resistant Schizophrenia

Schizophrenia | Schizo Affective Disorder | Treatment-resistant Schizophrenia

United States
AbbVie (prior sponsor, Abbott)

Completed

Safety and Efficacy Study for Cognitive Deficits in Adult Subjects With Schizophrenia

Cognitive Deficits in Schizophrenia

United States
Prague Psychiatric Center

Unknown

A RCT Study in Schizophrenia Relapse Prevention

Relapse Schizophrenia

Czech Republic
Massachusetts General Hospital

Not yet recruiting

The Effects of Auditory Stimulation During Sleep on Brain Networks in Schizophrenia

Schizophrenia

United States
Anavex Life Sciences Corp.
Cognitive Research Corporation; COGNISION; Hassman Research Institute

Recruiting

A Study of ANAVEX3-71 in Adults With Schizophrenia (SZ-001)

Schizophrenia

United States
King's College London

Recruiting

Energetics and Glutamate in Schizophrenia (EAGLES)

Schizophrenia

United Kingdom
University of Maryland, Baltimore
National Institute of Mental Health (NIMH)

Not yet recruiting

TMS for Inhibition Enhancement in Schizophrenia (TIES)

Schizophrenia
Vigonvita Life Sciences

Recruiting

Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy Volunteers

Schizophrenia

China
Università degli Studi di Ferrara

Recruiting

Exercise Intervention for People With Schizophrenia (CREW) (CREW)

Schizophrenia

Italy
Power Life Sciences Inc.

Not yet recruiting

An In Depth Study Evaluating The Experiences of Patients In Schizophrenia Research

Schizophrenia
First Affiliated Hospital Xi'an Jiaotong University

Not yet recruiting

A Study of the Efficacy of Fecal Microbiota Transplantation(FMT) in the Treatment of Schizophrenia

Schizophrenia
Click Therapeutics, Inc.
Boehringer Ingelheim

Recruiting

Study of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of Schizophrenia (CONVOKE)

Schizophrenia

United States
Anya Bershad, MD, PhD

Not yet recruiting

Tolerability of MDMA in Schizophrenia (TMS)

Schizophrenia
Shanghai Mental Health Center

Recruiting

Risk Prediction Model of Cardiovascular Events in Patients With Schizophrenia

Schizophrenia

China
Rovi Pharmaceuticals Laboratories

Recruiting

Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a Relapse (RESHAPE)

Schizophrenia

Germany
Centre Hospitalier Departemental Vendee

Not yet recruiting

Lost Children Society (LCS), Online Therapeutic Tabletop Role-playing Game for Early-onset Schizophrenia Patients (TTRPG)

Schizophrenia

France
Washington University School of Medicine

Recruiting

PET Imaging Study of α7 and α4β2-nAChR in Schizophrenia

Schizophrenia

United States
Central South University

Not yet recruiting

iTBS Can Increase Frontal Dopamine Release in PET Dopamine Imaging.

Schizophrenia

China
Sir Run Run Shaw Hospital

Not yet recruiting

Effect of Nicotine Transdermal Patch on Cognitive Function and Glycolipid Metabolism in Non-smoking Schizophrenia

Schizophrenia
Centre Psychothérapique de Nancy

Recruiting

EEG and Behavioral Correlates of Temporal Prediction in the Tactile Modality in Schizophrenia (SchizPredicT)

Schizophrenia

France
Zhejiang Jingxin Pharmaceutical Co., Ltd.

Recruiting

A Safety，Tolerability and Pharmacokinetics Clinical Trial of JX11502MA Capsule

Schizophrenia

China
Boehringer Ingelheim

Recruiting

A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study

Schizophrenia

Korea, Republic of, Canada, United States, Taiwan, United Kingdom, Chile, Serbia, Brazil, China, Colombia, Germany, Greece, Italy, Japan, Mexico, Norway, Poland, Sweden, Spain, Argentina, Croatia, France, Slovakia, Denmark, Malaysia, Czechia and more
Saglik Bilimleri Universitesi

Recruiting

The Effect of Psychoeducation Program on Healthy Living Behaviors

Schizophrenia

Turkey
Reviva Pharmaceuticals

Recruiting

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia (RECOVER)

Schizophrenia

United States

Clinical Trials on Schizophrenia, Paranoid

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations